- Home
- WERN vs SLNO Comparison
WERN vs SLNO Comparison
Compare WERN & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WERN | SLNO |
|---|---|---|
| Founded | 1956 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WERN | SLNO |
|---|---|---|
| Price | $40.78 | $53.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $33.79 | ★ $83.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.59 |
| Revenue | ★ $2,974,396,000.00 | $1,450,788.00 |
| Revenue This Year | $22.24 | $150.46 |
| Revenue Next Year | $6.33 | $50.37 |
| P/E Ratio | ★ N/A | $89.83 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $23.06 | $29.43 |
| 52 Week High | $40.11 | $89.12 |
Technical Indicators
Market Signals| Indicator | WERN | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 73.20 | 77.32 |
| Support Level | $30.30 | $48.91 |
| Resistance Level | N/A | $55.47 |
| Average True Range (ATR) | 1.48 | 0.05 |
| MACD | 0.34 | -0.52 |
| Stochastic Oscillator | 95.15 | 100.00 |
Price Performance
Historical ComparisonAbout WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.